Skip to main content

Advertisement

Springer Nature Link
Log in

Colorectal cancer screening utilization among breast, cervical, prostate, skin, and lung cancer survivors

  • Published:
Journal of Cancer Survivorship Aims and scope Submit manuscript

Abstract

Purpose

To examine whether sociodemographic characteristics, access to care, risk behavior factors, and chronic health conditions were associated with colorectal cancer (CRC) screening utilization among breast, cervical, prostate, skin, and lung cancer survivors.

Methods

We analyzed the 2020 Behavioral Risk Factor Surveillance System (BRFSS) data on 9780 eligible cancer survivors. Descriptive statistics and multivariable logistic regression models were applied to assess the association between guideline-concordant CRC screening and the mentioned characteristics.

Results

Overall, 81.9%, 65%, 88%,78.1%, and 80.1% of breast, cervical, prostate, skin, and lung cancer survivors received CRC screening, respectively (p-value < 0.001). In multivariable analysis, breast, cervical, and skin cancer survivors aged 60 years or older were associated with higher odds of receiving CRC screening. Respondents that had their recency of routine checkup two or more years before had lower odds of having CRC screening among cervical (OR = 0.06; 95% CI, 0.02–0.22), prostate (OR = 0.26; 95% CI, 0.14–0.49), and skin cancer (OR = 0.50; 95% CI, 0.36–0.70) survivors. The presence of chronic diseases was also associated with guideline-concordant CRC screening among breast, prostate, and skin cancer survivors.

Conclusions

Our findings provide important evidence on potential factors that are associated with guideline-concordant CRC screening utilization across different cancer survivors, which include older age, recency of routine checkup, and multiple chronic diseases. Moreover, variation in CRC screening utilization across cancer survivors may highlight missed opportunities for secondary cancer prevention.

Implications for Cancer Survivors

Establishing clear CRC screening guidelines and including patient-provider communication on recommendation in cancer survivorship care may increase adherence to CRC screening.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Data availability

The datasets generated during the current study are available in the Center for Disease Control and Prevention repository, https://www.cdc.gov/brfss/.

References

  1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.

    Article  PubMed  Google Scholar 

  2. Brenner H, Chen C. The colorectal cancer epidemic: challenges and opportunities for primary, secondary and tertiary prevention. Br J Cancer. 2018;119(7):785–92.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.

  4. Secondary Primary Cancers. Available from: https://dceg.cancer.gov/research/what-we-study/second-cancers. Accessed May 31, 2022.

  5. Desautels D, Czaykowski P, Nugent Z, Demers AA, Mahmud SM, Singh H. Risk of colorectal cancer after the diagnosis of prostate cancer: a population-based study. Cancer. 2016;122(8):1254–60.

    Article  PubMed  Google Scholar 

  6. Baxter NN, Tepper JE, Durham SB, Rothenberger DA, Virnig BA. Increased risk of rectal cancer after prostate radiation: a population-based study. Gastroenterology. 2005;128(4):819–24.

    Article  PubMed  Google Scholar 

  7. Davis EJ, Beebe-Dimmer JL, Yee CL, Cooney KA. Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study. Cancer. 2014;120(17):2735–41.

    Article  PubMed  Google Scholar 

  8. Travis LB. Controversies: therapy-associated solid tumors. Acta Oncol. 2002;41:323–33.

    Article  PubMed  Google Scholar 

  9. Travis LB, Rabkin C, Brown LM, Allan JM, Alter BP, Ambrosone CB, et al. Cancer survivorship—genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst. 2006;98:15–25.

    Article  PubMed  Google Scholar 

  10. Molina-Montes E, Requena M, Sánchez-Cantalejo E, Fernández MF, Arroyo-Morales M, Espín J, Arrebola JP, et al. Risk of second cancers cancer after a first primary breast cancer: a systematic review and meta-analysis. Gynecol Oncol. 2015;136(1):158–71.

    Article  PubMed  Google Scholar 

  11. American Cancer Society, After cervical cancer treatment. Available from: https://www.cancer.org/content/dam/CRC/PDF/Public/8603.00.pdf. Accessed 3 May 2022.

  12. Kato T, Suzuki K, Muto Y, Sasaki J, Tsujinaka S, Kawamura YJ, et al. Multiple primary malignancies involving primary sporadic colorectal cancer in Japan: incidence of gastric cancer with colorectal cancer patients may be higher than previously recognized. World J Surg Oncol. 2015;13:23.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Samo S, Sherid M, Husein H, Sulaiman S, Vainder JA. Metastatic malignant melanoma to the colon: a case report and review of the literature. J Gastrointest Cancer. 2014;45(2):221–4.

    Article  PubMed  Google Scholar 

  14. Mariotto AB, Ries L, Scoppa S, Feuer E. Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev. 2007;16(3):566–71.

    Article  PubMed  Google Scholar 

  15. US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, et al. Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(19):1965–77.

    Article  Google Scholar 

  16. American Cancer Society Guideline for Colorectal Cancer Screening. Available from: https://www.cancer.org/cancer/colon-rectal-cancer/detection-diagnosis-staging/acs-recommendations.html#written_by9. Accessed 31 May 2022.

  17. Richardson LC, King JB, Thomas CC, Richards TB, Dowling NF, Coleman King S. Adults Who have never been screened for colorectal cancer, behavioral risk factor surveillance system, 2012 and 2020. Prev Chronic Dis. 2022;19:220001.

    Article  Google Scholar 

  18. Homan SG, Kayani N, Risk YS. Risk factors, preventive practices, and health care among breast cancer survivors, United States, 2010. Prev Chronic Dis. 2016;13:E09.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Mandelzweig L, Chetrit A, Amitai T, Silverman B, Siegelmann-Danieli N, Sadetzki S. Primary prevention and screening practices among long-term breast cancer survivors. Cancer Causes Control. 2017;28(7):657–66.

    Article  PubMed  Google Scholar 

  20. Breslau ES, Jeffery DD, Davis WW, Moser RP, McNeel TS, Hawley S. Cancer screening practices among racially and ethnically diverse breast cancer survivors: results from the 2001 and 2003 California health interview survey. J Cancer Surviv. 2010;4(1):1–14.

    Article  PubMed  Google Scholar 

  21. Salz T, Weinberger M, Ayanian JZ, Brewer NT, Earle CC, Elston Lafata J, et al. Variation in use of surveillance colonoscopy among colorectal cancer survivors in the United States. BMC Health Serv Res. 2010;10:256.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Dash C, Lu J, Parikh V, Wathen S, Shah S, Shah Chaudhari R, et al. Disparities in colorectal cancer screening among breast and prostate cancer survivors. Cancer Med. 2021;10(4):1448–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Huang Y, Soon YY, Ngo LP, Dina Ee YH, Tai BC, Wong HC, et al. A cross-sectional study of knowledge, attitude, and barriers to colorectal cancer screening among cancer survivors. Asian Pac J Cancer Prev. 2019;20(6):1817–24.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Shay LA, Schmidt S, Dioun SI, Grimes A, Embry L. Receipt of a survivorship care plan and self-reported health behaviors among cancer survivors. J Cancer Surviv. 2019;13(2):180–6.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Centers for Disease Control and Prevention (CDC). Behavioral risk factor surveillance system survey data. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2020.

  26. Wolf AMD, Fontham ETH, Church TR, Flowers CR, Guerra CE, LaMonte SJ, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68(4):250–81.

    Article  PubMed  Google Scholar 

  27. Esser MB, Hedden SL, Kanny D, Brewer RD, Gfroerer JC, Naimi TS. Prevalence of alcohol dependence among US adult drinkers, 2009–2011. Prev Chronic Dis. 2014;11:140329.

    Article  Google Scholar 

  28. Sacks JJ, Gonzales KR, Bouchery EE, Tomedi LE, Brewer RD. 2010 national and state costs of excessive alcohol consumption. Am J Prev Med. 2015;49(5):e73–9.

    Article  PubMed  Google Scholar 

  29. Stahre M, Roeber J, Kanny D, Brewer RD, Zhang X. Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States. Prev Chronic Dis. 2014;11:130293.

    Article  Google Scholar 

  30. Greiner B, Gandhi R, Abrol R, Patel M, Hartwell M. National disparities in colorectal cancer screening in patients with comorbid conditions: an analysis of the Behavioral Risk Factor Surveillance System. J Osteopath Med. 2021;121(7):657–62.

    Article  PubMed  Google Scholar 

  31. Glenn BA, Nonzee NJ, Hamilton AS, Tieu L, Maxwell AE, Crespi CM, et al. Cancer surveillance and preventive services in a diverse sample of breast and colorectal cancer survivors. J Cancer Surviv. 2021;15(2):213–23.

    Article  PubMed  Google Scholar 

  32. Senkomago V, Greek A, Jackson JE, Thomas CC, Richardson LC, Benard VB. Learning from cervical cancer survivors: an examination of barriers and facilitators to cervical cancer screening among women in the United States. J Prim Care Community Health. 2021;12:21501327211041864.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Tsai MH, Cabral DN, Gishe J, Dagne GA. Colorectal cancer risk perceptions in Black Men, submitted to 2022 Society for Epidemiologic Research Annual Meeting, Jun 14–17, 2022. Poster session.

  34. Taha H, Jaghbeer MA, Al-Sabbagh MQ, Al Omari L, Berggren V. Knowledge and practices of colorectal cancer early detection examinations in Jordan: a cross sectional study. Asian Pac J Cancer Prev. 2019;20(3):831–8.

    Article  PubMed  PubMed Central  Google Scholar 

  35. MacDonald M, Mirza AS, Mhaskar R, Ewing A, Chen L, Robinson K, et al. Preventative cancer screening rates among uninsured patients in free clinics: a retrospective cohort study of cancer survivors and non-cancer survivors. Cancer Control. 2022;29:10732748211072984.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Bardou M, Barkun AN, Martel M. Obesity and colorectal cancer. Gut. 2013;62(6):933–47.

    Article  CAS  PubMed  Google Scholar 

  37. Sussman J, Bainbridge D, Evans WK. Towards integrating primary care with cancer care: a regional study of current gaps and opportunities in Canada. Healthc Policy. 2017;12:50–65.

    PubMed  PubMed Central  Google Scholar 

  38. Smith TG, Strollo S, Hu X, Earle CC, Leach CR, Nekhlyudov L. Understanding long-term cancer survivors’ preferences for ongoing medical care. J Gen Intern Med. 2019;34(10):2091–7.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Lawrence RA, McLoone JK, Wakefield CE, Cohn RJ. Primary care physicians’ perspectives of their role in cancer care: a systematic review. J Gen Intern Med. 2016;31(10):1222–36.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Sutton AL, He J, Edmonds MC, Sheppard VB. Medical mistrust in Black breast cancer patients: acknowledging the roles of the trustor and the trustee. J Cancer Educ. 2019;34(3):600–7.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Adams LB, Richmond J, Corbie-Smith G, Powell W. Medical mistrust and colorectal cancer screening among African Americans. J Community Health. 2017;42(5):1044–61.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Haviland K, Burrows Walters C, Newman S. Barriers to palliative care in sexual and gender minority patients with cancer: a scoping review of the literature. Health Soc Care Community. 2021;29(2):305–18.

    Article  PubMed  Google Scholar 

  43. Gupta S, Cole AP, Marchese M, Wang Y, Speed JM, Fletcher SA, et al. Use of preventive health services among cancer survivors in the US. Am J Prev Med. 2018;55(6):830–8.

    Article  PubMed  Google Scholar 

  44. Maxwell AE, Lucas-Wright A, Chang LC, Santifer RE, Crespi CM. Factors associated with colorectal cancer screening in a peer-counseling intervention study in partnership with African American churches. Prev Med Rep. 2020;20:101280.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Lafata JE, Cooper G, Divine G, Oja-Tebbe N, Flocke SA. Patient-physician colorectal cancer screening discussion content and patients’ use of colorectal cancer screening. Patient Educ Couns. 2014;94(1):76–82.

    Article  PubMed  Google Scholar 

  46. Islam KM, Jiang X, Anggondowati T, Lin G, Ganti AK. Comorbidity and survival in lung cancer patients. Cancer Epidemiol Biomarkers Prev. 2015;24(7):1079–85.

    Article  PubMed  Google Scholar 

  47. Maratt JK, Calderwood AH. Colorectal cancer screening and surveillance colonoscopy in older adults. Curr Treat Options Gastroenterol. 2019;17(2):292–302.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Bai X, Wei H, Liu W, Coker OO, Gou H, Liu C, et al. Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites. Gut. 2022:gutjnl-2021–325021.

  49. Rossi M, Jahanzaib Anwar M, Usman A, Keshavarzian A, Bishehsari F. Colorectal cancer and alcohol consumption-populations to molecules. Cancers (Basel). 2018;10(2):38.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Mazidimoradi A, Tiznobaik A, Salehiniya H. Impact of the COVID-19 pandemic on colorectal cancer screening: a systematic review. J Gastrointest Cancer. 2021;1–15.

Download references

Acknowledgements

Justin X. Moore was supported by the National Institute on Minority Health and Health Disparities of the National Institutes of Health under Award Number K01MD015304. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. In addition, this research was supported at least in part through the Georgia Cancer Center Paceline funding mechanism (principal investigator: Meng-Han Tsai). Thanks to all co-authors in completing this manuscript.

Author information

Authors and Affiliations

  1. Cancer Prevention, Control, and Population Health Program, Georgia Cancer Center, Department of Medicine, Medical College of Georgia, Augusta University, 1410 Laney Walker Boulevard CN-2116, Augusta, GA, 30912, USA

    Meng-Han Tsai, Justin X. Moore, Sydney E. Andrzejak & Martha S. Tingen

  2. Georgia Prevention Institute, Augusta University, 1457 Walton Way, Augusta, GA, 30901, USA

    Meng-Han Tsai & Martha S. Tingen

  3. Institute of Public and Preventive Health, Augusta University, 1120 15th Street, Augusta, GA, 30912, USA

    Justin X. Moore & Lorriane A. Odhiambo

Authors
  1. Meng-Han Tsai
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Justin X. Moore
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Lorriane A. Odhiambo
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Sydney E. Andrzejak
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Martha S. Tingen
    View author publications

    You can also search for this author inPubMed Google Scholar

Contributions

All authors contributed to the study conception. Material preparation and data analysis were performed by Meng-Han Tsai and Justin X. Moore. The first draft of the manuscript was written by Meng-Han Tsai and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Meng-Han Tsai.

Ethics declarations

Ethics approval

The respective health departments from each state grant Institutional Review Board (IRB) approval for the distribution and collection of data using the BRFSS. Data extracted for this study were publicly available and de-identified and thus considered exempt from IRB review at Augusta University. This article does not include any studies with animals performed by any of the authors.

Consent to participate

Verbal informed consent was obtained from all individual participants included in the study as per the BRFSS process for data collection.

Consent for publication

This study does not include any individual person’s data in any form (including any individual details, images, or videos).

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 45.6 KB)

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tsai, MH., Moore, J.X., Odhiambo, L.A. et al. Colorectal cancer screening utilization among breast, cervical, prostate, skin, and lung cancer survivors. J Cancer Surviv 18, 541–552 (2024). https://doi.org/10.1007/s11764-022-01258-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11764-022-01258-0

Keywords